Latest filing published 11 Sept 2026 for NovaBridge Biosciences, €69k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sean Wuxiong Cao: trading record in brief
All filings by Sean Wuxiong Cao on record concern NovaBridge Biosciences. We count 3 filings; the first trade dates from 3 September 2026 and the latest from 9 September 2026.
The open-market record consists of 1 sale worth €69k, with no purchase. Outside the open market, there are 2 option exercises.
Most recently, on 11 September 2026, the filings show an open-market sale worth €69k in NovaBridge Biosciences. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sean Wuxiong Cao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 107,978 shares@ US$0.74Ordinary SharesSEC:0002109966-26-000008:0
- 235,136 sharesOrdinary SharesSEC:0002109966-26-000006:0
- 104,236 sharesOrdinary SharesSEC:0002109966-26-000006:1
3 of 3 declarations